Changes in collagenases and TGF-β precede structural alterations in a model of chronic renal fibrosis

Kidney International

Volumn 56, Issue 1, 1999, Pages 145-153

  Mo, Wa ^b   Brecklin, Carolyn ^b   Garber, Sandra L ^b   Song, Ruo H ^b   Pegoraro, Alfredo A ^b   Au, Julienne ^b   Arruda, Jose A L ^b   Dunea, George ^b   Singh, Ashok K ^a  

^a Hektoen Institute for Medical Research   (United States)

^b NONE

Author keywords

Bromoethylamine; Collagenases; Gelatinases; Interstitial fibrosis; Papillary necrosis; TIMP; Transforming growth factor

Indexed keywords

2 BROMOETHYLAMINE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; COLLAGENASE; GELATINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROGENESIS; KIDNEY CORTEX; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; KIDNEY MEDULLA; KIDNEY PAPILLA NECROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT;

EID: 0033032291     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00545.x     Document Type: Article

References (11)

1. PALMER B: The renal tubule in the progression of chronic renal failure. J Invest Med 45:346-361, 1997
2. ARRUDA JAL, SABATINI S, MEHTA PK, SODHI B, BARANOWSKI R: Functional characterization of drug-induced experimental papillary necrosis. Kidney Int 15:264-275, 1979
3. GARBER SL, MIROCHNIK Y, ARRUDA JAL, DUNEA G: Evolution of experimentally induced papillary necrosis to focal segmental glomerulosclerosis and nephrotic proteinuria. Am J Kidney Dis 33:1-8, 1999
4. GARBER SL, MIROCHNIK Y, DESAI SS, ARRUDA JAL, DUNEA G: Angiotensin-converting enzyme inhibition reduces the effect of bromoethylamine-induced papillary necrosis and renal fibrosis. J Am Soc Nephrol 9:1052-1059, 1998
5. MURRAY G, WYLLIE RG, HILL GS, RAMSDEN PW, HEPTINSTALL RH: Experimental papillary necrosis of the kidney. I. Morphologic and functional data. Am J Pathol 67:285-302, 1972
6. STRUTZ F, MULLER GA: Renal fibrosis and progression, in Immunologic Renal Disease, edited by NEILSON EG, COUSER WG, Philadelphia, Lippincott-Raven, 1997, pp 705-726
7. BURKEDAL-HANSEN H: Role of matrix metallo-proteinases in human periodontal disease. J Periodontal 64:474-484, 1993
8. EDWARDS DR, BEAUDRY PP, LAING TD, KOWAL V, LECO KJ, LECO PA, LIM MS: The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth. Int J Obesity 20(Suppl 3):S9-S15, 1996
9. SHARMA BS, ZIYADEH FN: The emerging role of TGF β (transforming growth factor β) in kidney diseases. Am J PhysioI35:F829-F842, 1994
10. LEEHEY DJ, SONG RH, ALAVI N, SINGH AK: Decreased degradative enzymes in mesangial cells cultured in high glucose media. Diabetes 44:929-935, 1995
11. SINGH AK, MO W, DUNEA G, ARRUDA JAL: Effect of glycated proteins on the matrix of glomerular epithelial cells. J Am Soc Nephrol 9:802-810, 1998